Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic
For Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic, agency is HHS; statutory authority is 1395w-3a(d)(4)(A); maximum penalty is 17,062, recorded from its source on 2026-08-10.
- Agency
- HHS our reading
- Violation
- Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic verified
- Statutory authority
- 1395w-3a(d)(4)(A) verified
- Maximum penalty
- 17,062 verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
What the source says
1395w-3a(d)(4)(A) | <https://www.ecfr.gov/current/title-42/section-414.806> 42 CFR 414.806 | CMS | Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic | 2024 | 16,630 | 17,062
— ecfr.gov, retrieved 2026-08-10
Source
- ecfr.govhttps://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-102/section-102.3